Irie Y et al. |
Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301989
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301991
|
Gisbert JP et al. |
[What is the current role of clarithromycin in the eradication of Helicobacter pylori?]. |
1997 |
Rev Esp Enferm Dig |
pmid:9221019
|
Matsumoto T et al. |
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:9228971
|
Kadayifçi A et al. |
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis. |
1997 |
Ann Pharmacother |
pmid:9184727
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Götz JM et al. |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. |
1997 |
Gut |
pmid:9203935
|
Verhaegen J et al. |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae. |
1997 |
Acta Clin Belg |
pmid:9204588
|
Kim MJ et al. |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment. |
1997 |
Gastroenterology |
pmid:9207259
|
Gotoh A et al. |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. |
1997 |
Microbiol. Immunol. |
pmid:9087962
|
Driscoll MS and Tyring SK |
Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. |
1997 |
J. Am. Acad. Dermatol. |
pmid:9091495
|
Gui GP et al. |
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096189
|
Hoogkamp-Korstanje JA et al. |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096192
|
Fujii K et al. |
Multiple primary Mycobacterium avium infection of the skin. |
1997 |
Int. J. Dermatol. |
pmid:9071619
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin. |
1997 |
Epidemiol. Infect. |
pmid:9129588
|
Fietta A et al. |
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. |
1997 |
J Chemother |
pmid:9106013
|
Chaisson RE et al. |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. |
1997 |
AIDS |
pmid:9147422
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
DÃaz F et al. |
[Cat-scratch disease. A report of 4 cases and a review of the literature]. |
1997 |
Rev Clin Esp |
pmid:9102668
|
Szczebara F et al. |
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9105846
|
Arguedas A et al. |
Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion. |
1997 |
J Chemother |
pmid:9106017
|
Yanagihara K et al. |
Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. |
1997 |
Am. J. Respir. Crit. Care Med. |
pmid:9001333
|
Horgen L et al. |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. |
1997 |
Res. Microbiol. |
pmid:9765852
|
Denys A |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. |
1997 |
Otolaryngol Pol |
pmid:9757681
|
Pendland SL et al. |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. |
1997 |
J. Clin. Microbiol. |
pmid:9350781
|
Kubas G and Gospodarek T |
[The use of clarithromycin and amoxycillin in pediatric acute otitis media]. |
1997 |
Otolaryngol Pol |
pmid:9757683
|
Burman WJ et al. |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements. |
1997 |
Int. J. Tuberc. Lung Dis. |
pmid:9441082
|
Brady RC et al. |
Facial sporotrichoid infection with Mycobacterium marinum. |
1997 |
J. Pediatr. |
pmid:9042142
|
Suzuki K et al. |
Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages. |
1997 |
Int. J. Tuberc. Lung Dis. |
pmid:9441102
|
Axon AT et al. |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042977
|
Gotoh A et al. |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori. |
1997 |
Microbiol. Immunol. |
pmid:9444328
|
Labenz J et al. |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042978
|
Labenz J et al. |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042979
|
Prattichizzo FA et al. |
[Carditis associated with Mycoplasma pneumoniae infection. Clinical aspects and therapeutic problems]. |
1997 |
Minerva Cardioangiol |
pmid:9446067
|
Erah PO et al. |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. |
1997 |
J. Antimicrob. Chemother. |
pmid:9044021
|
Genné D et al. |
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9447898
|
Roche B et al. |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. |
1997 |
Rev Rhum Engl Ed |
pmid:9051864
|
Ridgway GL et al. |
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. |
1997 |
J. Antimicrob. Chemother. |
pmid:9484871
|
Martin SJ et al. |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9401809
|
Sander P et al. |
The role of ribosomal RNAs in macrolide resistance. |
1997 |
Mol. Microbiol. |
pmid:9402018
|
Brancato R et al. |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. |
1997 |
Arch. Ophthalmol. |
pmid:9338681
|
Jingu K et al. |
[A case of fluminant Mycoplasma pneumonia and bronchiolitis managed by artificial respiration]. |
1997 |
Nippon Naika Gakkai Zasshi |
pmid:9340346
|
Yamamoto M et al. |
[The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection]. |
1997 |
Kekkaku |
pmid:9038009
|
Goh KL et al. |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection? |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663838
|
Kolkman JJ et al. |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663840
|
Miyaji H et al. |
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663841
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Greco S et al. |
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. |
1997 |
Ann Pharmacother |
pmid:9416400
|
Sugihara J et al. |
[Efficacy of clarithromycin on chronic paranasal sinusitis--a comparison between children and adult]. |
1997 |
Jpn J Antibiot |
pmid:9597431
|
Hamada K et al. |
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. |
1997 |
Jpn J Antibiot |
pmid:9597434
|
Buckley MJ et al. |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. |
1997 |
Dig. Dis. Sci. |
pmid:9365144
|
Dautzenberg B |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. |
1997 |
Drugs |
pmid:9358194
|
Misiewicz JJ et al. |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. |
1997 |
Gut |
pmid:9462204
|
Cohn DL |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. |
1997 |
Drugs |
pmid:9358195
|
Loo VG et al. |
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. |
1997 |
J. Antimicrob. Chemother. |
pmid:9462442
|
Hoffner SE et al. |
In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis. |
1997 |
J. Antimicrob. Chemother. |
pmid:9462443
|
Torresani C et al. |
Clarithromycin versus doxycycline in the treatment of rosacea. |
1997 |
Int. J. Dermatol. |
pmid:9466207
|
Tzivras M et al. |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9471024
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
McLaren A et al. |
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics. |
1997 |
Helicobacter |
pmid:9432317
|
Bardhan KD et al. |
Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole. |
1997 |
Helicobacter |
pmid:9432318
|
Takimoto T et al. |
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. |
1997 |
Helicobacter |
pmid:9432334
|
Moayyedi P |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin? |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9513823
|
Pieramico O et al. |
Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial. |
1997 |
Helicobacter |
pmid:9432335
|
Pounder RE et al. |
Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing. |
1997 |
Helicobacter |
pmid:9432341
|
Konishi T and Nakao M |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. |
1997 |
Microbiol. Immunol. |
pmid:9087959
|
GarcÃa-de-Lomas J et al. |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063666
|
Weiss I et al. |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063669
|
Bordet AL et al. |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. |
1997 |
Ann Dermatol Venereol |
pmid:9686059
|
Cammarota G et al. |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication. |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9476192
|
Hotz J |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram]. |
1997 |
Fortschr. Med. |
pmid:9480263
|
Thornsberry C et al. |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9458982
|
Briant C et al. |
Pericarditis as a manifestation of Lyme disease. |
1997 |
J Emerg Nurs |
pmid:9460386
|
Feldman C et al. |
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. |
1997 |
Inflammation |
pmid:9429912
|
Lévy M et al. |
Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. |
1997 |
Gastrointest. Endosc. |
pmid:9351036
|
Laine L et al. |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354200
|
Rinaldi V et al. |
The management of failed dual or triple therapy for Helicobacter pylori eradication. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354202
|
Breuer T et al. |
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354204
|
Wurzer H et al. |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354205
|
Misiewicz JJ |
Management of Helicobacter pylori-related disorders. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9160212
|
Hultén K et al. |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371366
|
Barry AL et al. |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9405952
|
Mitsuyama T et al. |
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9338603
|
Ando H et al. |
[Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori]. |
1997 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:9396326
|
Hirakawa T |
[Diagnosis and treatment of Helicobacter pylori]. |
1997 |
Nippon Ika Daigaku Zasshi |
pmid:9283206
|
Fietta A et al. |
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. |
1997 |
J Chemother |
pmid:9106014
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Chimura T |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. |
1997 |
Jpn J Antibiot |
pmid:9212369
|
Lim AG et al. |
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218079
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Midolo PD et al. |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. |
1997 |
Pathology |
pmid:9423225
|
Srinivasan R and Minocha A |
Cure of Helicobacter pylori: a hidden curse? |
1997 |
Am. J. Gastroenterol. |
pmid:9399784
|
|
Different clarithromycin doses affect mortality. |
1997 |
AIDS Patient Care STDS |
pmid:11361754
|
Sekkarie MA |
Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin. |
1997 |
Am. J. Kidney Dis. |
pmid:9292575
|
Akaki T et al. |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice]. |
1997 |
Kekkaku |
pmid:9293712
|
Recker MW and Kier KL |
Potential interaction between clarithromycin and warfarin. |
1997 |
Ann Pharmacother |
pmid:9296238
|
Laberge P and Martineau P |
Clarithromycin-induced digoxin intoxication. |
1997 |
Ann Pharmacother |
pmid:9296239
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. |
1997 |
Gut |
pmid:9301496
|